Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors combination therapy versus monotherapy and major adverse cardiovascular events: Do the benefits add up?
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:0953-6205
-
Container-title:European Journal of Internal Medicine
-
language:en
-
Short-container-title:European Journal of Internal Medicine
Author:
Karakasis PaschalisORCID,
Patoulias Dimitrios,
Fragakis NikolaosORCID,
Bernal-López María RosaORCID,
Gómez-Huelgas RicardoORCID